Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Melcher

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
Blood|February 26, 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphomaVan Thuy Mai Nguyen, Hiroe Namba, Hayley Porter, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideCandice Willmon, Rosa M Diaz, Phonphimon Wongthida, et al.
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanomaHardev S Pandha, Lucy Heinemann, Guy R Simpson, et al.
Cell Death Discovery|December 9, 2020
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patientsAnguraj Sadanandam, Tobias Bopp, Santosh Dixit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Timothy Kottke, Jill Thompson, Rosa Maria Diaz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2020
Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapyPablo Nenclares, Sheerang A Bhide, Helena Sandoval-Insausti, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
Blood|February 26, 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphomaVan Thuy Mai Nguyen, Hiroe Namba, Hayley Porter, et al.
Human Gene Therapy|March 4, 2011
Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virusPhonphimon Wongthida, Rosa Maria Diaz, Christine Pulido, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 28, 2010
Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamideCandice Willmon, Rosa M Diaz, Phonphimon Wongthida, et al.
Cancer Research|May 21, 2010
Type III IFN interleukin-28 mediates the antitumor efficacy of oncolytic virus VSV in immune-competent mouse models of cancerPhonphimon Wongthida, Rosa Maria Diaz, Feorillo Galivo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2009
Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanomaHardev S Pandha, Lucy Heinemann, Guy R Simpson, et al.
Cell Death Discovery|December 9, 2020
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patientsAnguraj Sadanandam, Tobias Bopp, Santosh Dixit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2Timothy Kottke, Jill Thompson, Rosa Maria Diaz, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2020
Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapyPablo Nenclares, Sheerang A Bhide, Helena Sandoval-Insausti, et al.
Cancer Research|October 3, 2002
Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusionEmmanouela Linardakis, Andrew Bateman, Vy Phan, et al.
Human Gene Therapy|November 20, 2009
Interference of CD40L-mediated tumor immunotherapy by oncolytic vesicular stomatitis virusFeorillo Galivo, Rosa Maria Diaz, Uma Thanarajasingam, et al.
Pageof 14